Nanoemulsion is an effective antimicrobial for methicillin-resistant Staphylococcus aureus in infected swine skin burn wounds
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.01378-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Zhengyi Cao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Burns, Emulsions, Anti-Bacterial Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Burns are one of the most common injuries in both civilian and combat settings and are difficult to treat. This is particularly true when the wounds are infected with antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA). A new generation of safe, broadly effective, and easily applied anti-infection agents is needed to successfully prevent and treat infections. Nanoemulsions (NEs) are nanometer-sized particles with a positively charged surfactant at their oil-water interface. In the current study, we further investigated antimicrobial NEs as a treatment to address burn wounds infected by MRSA. Specifically, using a porcine skin model, we infected partial thickness thermal burn wounds with MRSA and then treated it with the nanoemulsion formulation (NB-201) or placebo controls. Bacterial viability after treatment was determined, and inflammation indexes in wounds were scored by histopathology. Topical treatment of infected wounds with NB-201 resulted in reduced colony-forming units (CFUs) compared to placebo treatment. In addition, NB-201 was effective in significantly alleviating inflammation in the treated wounds and promoting wound healing. These results indicate that NB-201 is a promising new agent to treat skin burn wounds infected with MRSA. IMPORTANCE The findings of this study are focused on therapeutic applications of nanotechnology. In the current study, we demonstrated that a nanoemulsion formulation could effectively kill methicillin-resistant Staphylococcus aureus (MRSA) infection in porcine skin burn wounds. Infection of MRSA in burn wound is a common threat to public health and is usually difficult to treat due to limited therapies available. NB-201 was effective in significantly alleviating inflammation in the treated wounds and promoting wound healing. Therefore, the finding of this study has a great potential to make this formulation a novel antimicrobial agent against MRSA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Internal Medicine, Division of Allergy, University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: Jesse Chen, Su He Wang
Zitieren
APA
Cao, Z., Chen, J., Cannon, J., Meyer, Z., Li, Y., Ouyang, W., Baker, J., & Wang, S. H. (2024). Nanoemulsion is an effective antimicrobial for methicillin-resistant Staphylococcus aureus in infected swine skin burn wounds. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01378-24
Vancouver
Cao Z, Chen J, Cannon J, Meyer Z, Li Y, Ouyang W, et al. Nanoemulsion is an effective antimicrobial for methicillin-resistant Staphylococcus aureus in infected swine skin burn wounds. Microbiology Spectrum. 2024. doi:10.1128/spectrum.01378-24
BibTeX
@article{Cao2024,
author = {Cao, Zhengyi and Chen, Jesse and Cannon, Jayme and Meyer, Zachary and Li, Yongqing and Ouyang, Wenlu and Baker, James and Wang, Su He},
title = {Nanoemulsion is an effective antimicrobial for methicillin-resistant Staphylococcus aureus in infected swine skin burn wounds},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.01378-24}
}
EUVIMED